Search Results 911-920 of 17169 for treatment resistant depression
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
... care that focuses on the whole family's integral role in epilepsy treatment. ... drug-resistant epilepsy April 07, 2025, 02:16 p.m. CDT; (VIDEO) When seizures ...
Combined ibrutinib and venetoclax for treatment of patients with ibrutinib-resistant or double-refractory chronic lymphocytic leukaemia. Br J Haematol. 2022 ...
Depression and anxiety after a heart attack are ... Participants who were treated ... Mayo Clinic's SCAD Research Program also is studying possible treatments for ...
... Treat Subjects with Relapsed or Refractory ... treatment in patients with treatment-naive ALK-positive advanced NSCLC. ... resistant chronic lymphocytic leukemia.
A Study of the Combination of ACP-196 and Pembrolizumab in Subjects with Platinum-Refractory Metastatic Bladder Cancer · Share · Facebook · Twitter.
Our kids were worried about my depression and drug use. I didn't like what I was becoming." Her husband was in a similar boat. "He'd get up around 9 a.m. ...
These medicines, such as nortriptyline (Pamelor), are used mostly for depression. But in low doses, they're sometimes used to ease pain, control bruxism and ...
Clinical Trials · Veliparib and Topotecan Hydrochloride in Treating Patients with Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal ...
A Study to Evaluate Trifluridine/Tipiracil Combined with Bevacizumab vs Trifluridine/Tipiracil to Treat Patients with Refractory Metastatic Colorectal Cancer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.